Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 78-85

Bentham Science Publishers

Access to resources Recommend Favorite

Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV‐infected women starting therapy

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 798-808

John Wiley & Sons Inc

Access to resources Recommend Favorite

CONSTIPATION IN ELDERLY PATIENTS DUE TO DRUG THERAPY

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 4, Iss. 10, 1956-10 ,pp. : 1021-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Genotyping of CYP2B6 and therapeutic drug monitoring in an HIV-infected patient with high efavirenz plasma concentrations and severe CNS side-effects

By Mathiesen Sofie   Stenz Justesen Ulrik   Von Lüttichau Hans-Rudolf   Eg Hansen Ann-Brit  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 8, 2006-08 ,pp. : 733-735

Informa Healthcare

Access to resources Recommend Favorite